30 likes | 296 Views
Table 3 Immunotherapy in clinical trials for glioblastoma. Tanaka, S. et al . ( 2012) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.204.
E N D
Table 3Immunotherapy in clinical trials for glioblastoma Tanaka, S. et al. (2012) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.204